Efficacy and Tolerability of Angeliq in Thai Women
NCT00185328
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
Postmenopause
Interventions
DRUG:
Estradiol/DRSP (Angeliq, BAY86-4891)
Sponsor
Bayer